BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity
We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified b...
Saved in:
Published in | Medical oncology (Northwood, London, England) Vol. 29; no. 5; pp. 3272 - 3281 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.12.2012
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website
http://relibrca.rellife.com
. |
---|---|
AbstractList | We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com. We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com .We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com . We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and their relatives, sporadic breast cancer patients, and unrelated normal healthy females, of Indian ethnicity. Peripheral blood DNA was amplified by polymerase chain reaction, at BRCA1/2 coding exons and subject to nucleotide sequencing using ABI 3100 Genetic Analyzer. We observed BRCA1/BRCA2 mutations in 52 % early-onset breast cancer patients and in 57 % relatives. Deleterious mutations detected in early-onset patients and relatives were 187delAG, 632insT, 1052delT, Q759X, Q780X, R1203X, 5154delC, IVS14 + 1G > A, IVS17 + 1G > T, and 632insT in BRCA1 gene; and 4075delGT, 5076delAA, 6079delAGTT, and W3127X in BRCA2 gene. A high degree of penetrance of BRCA1/2 gene mutations was observed in the relatives. BRCA1/2 SNPs were identified in the Indian population, and association of BRCA1 haplotypes with breast cancer was investigated. A significantly increased frequency of the SNPs 203G/A, 3624A/G and 7470A/G SNPs in BRCA2 gene was observed in normal controls indicative of a protective effect of the SNPs. BRCA1 haplotype 2 was most frequently observed in our population. Our study indicates a high incidence of BRCA1/BRCA2 gene mutations in the Indian patients. The BRCA1/2 mutations and SNPs are detailed on our website http://relibrca.rellife.com . |
Author | Saranath, Dhananjaya Juwle, Abida |
Author_xml | – sequence: 1 givenname: Abida surname: Juwle fullname: Juwle, Abida organization: Molecular Medicine, Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd – sequence: 2 givenname: Dhananjaya surname: Saranath fullname: Saranath, Dhananjaya email: saranathd@aol.com organization: Molecular Medicine, Dhirubhai Ambani Life Sciences Centre, Reliance Life Sciences Pvt. Ltd |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22752604$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtLHTEYhkNR6qX9AW4k4MbN9OQymSRLPdhWkCq2he5CJvlGR-ZkxiSzOP_eHI9CEVoXuSye5yN53wO0E8YACB1R8oUSIheJMsJZRWhZTNeV_oD2qRC6opz-2Sl3LmRFREP20EFKD4QwKpj-iPYYk4I1pN5H4fx2eUYXm53hOwiAV3O2uR9DWvz8cZOwDR4_M_jeTsOY1xMk3AcMNg7rqmCQcRvBpoydDQ4inooOISc8dvgy-N4WON-H3vV5_QntdnZI8PnlPES_v178Wn6vrq6_XS7PripXE5Er6uumVaRz2rMaGq49sdZ2nPqW-q5theS14oqLtu5aabnmsibOE-G006oDfohOt3OnOD7OkLJZ9cnBMNgA45wMlUIxrpVq3kdZCbkpvCroyRv0YZxjKB8pAzlTslCkUMcv1NyuwJsp9isb1-Y19ALILeDimFKEzpRonjPP0faDocRs6jXbek2p12zqNbqY9I35Ovx_Dts6qbDhDuJfj_6n9AQwQbRS |
CODEN | MONCEZ |
CitedBy_id | crossref_primary_10_1007_s12282_022_01374_w crossref_primary_10_1016_j_prp_2022_153760 crossref_primary_10_1007_s11033_022_07129_2 crossref_primary_10_3390_cancers13040881 crossref_primary_10_1140_epjp_s13360_024_05961_y crossref_primary_10_1186_s12920_020_00850_6 crossref_primary_10_1039_C5RA14442F crossref_primary_10_1177_03000605211070757 crossref_primary_10_4103_CRST_CRST_101_19 crossref_primary_10_1007_s12291_025_01313_4 crossref_primary_10_1016_j_humgen_2022_201085 crossref_primary_10_1016_j_genrep_2019_100380 crossref_primary_10_3390_cimb46050281 crossref_primary_10_1186_s12885_018_4537_9 crossref_primary_10_4048_jbc_2013_16_1_50 crossref_primary_10_1007_s13277_016_5322_5 crossref_primary_10_1186_s12885_015_1516_2 crossref_primary_10_18632_oncotarget_16242 |
Cites_doi | 10.1007/s10549-004-0593-8 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P 10.1086/301903 10.1093/hmg/5.6.835 10.1111/j.1582-4934.2005.tb00350.x 10.1200/JCO.20.4.994 10.4161/cbt.1.1.33 10.1158/0008-5472.CAN-09-4563 10.1038/ng1294-399 10.1186/bcr70 10.1007/s12038-009-0048-9 10.1158/0008-5472.CAN-05-1241 10.1158/1078-0432.CCR-08-1211 10.1056/NEJM199705153362001 10.1093/hmg/6.2.285 10.1093/jnci/93.16.1215 10.1186/1471-2350-7-75 10.1038/ng1096-185 10.1002/humu.9082 10.1002/humu.9213 10.1136/jmg.2003.015867 10.1093/annonc/mdp037 10.1186/1471-2407-8-214 10.1371/journal.pone.0002024 10.1200/JCO.20.6.1480 10.1016/j.ejca.2006.01.055 10.1001/jama.1997.03550150046034 10.1073/pnas.081068398 10.1038/ng0495-439 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC 2012 Springer Science+Business Media New York 2012 |
Copyright_xml | – notice: Springer Science+Business Media, LLC 2012 – notice: Springer Science+Business Media New York 2012 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 8FD FR3 P64 RC3 |
DOI | 10.1007/s12032-012-0294-9 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | Genetics Abstracts ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1559-131X |
EndPage | 3281 |
ExternalDocumentID | 3865294821 22752604 10_1007_s12032_012_0294_9 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | India |
GeographicLocations_xml | – name: India |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40E 53G 5GY 5RE 5VS 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACCUX ACDTI ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACUDM ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI H13 HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M1P M4Y MA- N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 PZZ Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z7U Z82 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ZXP ~A9 ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI PUEGO 7X8 8FD FR3 P64 RC3 |
ID | FETCH-LOGICAL-c405t-1d46b80fc9d24e639d0aaaf31db1dfbb573483835b4fb7a393740cd05c9c98fe3 |
IEDL.DBID | U2A |
ISSN | 1357-0560 1559-131X |
IngestDate | Thu Jul 10 21:57:05 EDT 2025 Fri Jul 11 04:43:32 EDT 2025 Sat Aug 23 14:49:09 EDT 2025 Thu Apr 03 07:07:06 EDT 2025 Tue Jul 01 01:49:07 EDT 2025 Thu Apr 24 23:09:46 EDT 2025 Fri Feb 21 02:33:49 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | SNPs Mutations Indian patients Early-onset/sporadic breast cancer Haplotype |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c405t-1d46b80fc9d24e639d0aaaf31db1dfbb573483835b4fb7a393740cd05c9c98fe3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 22752604 |
PQID | 1732877580 |
PQPubID | 30753 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1758239886 proquest_miscellaneous_1220367588 proquest_journals_1732877580 pubmed_primary_22752604 crossref_citationtrail_10_1007_s12032_012_0294_9 crossref_primary_10_1007_s12032_012_0294_9 springer_journals_10_1007_s12032_012_0294_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-12-01 |
PublicationDateYYYYMMDD | 2012-12-01 |
PublicationDate_xml | – month: 12 year: 2012 text: 2012-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: United States – name: Middlesex |
PublicationTitle | Medical oncology (Northwood, London, England) |
PublicationTitleAbbrev | Med Oncol |
PublicationTitleAlternate | Med Oncol |
PublicationYear | 2012 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | TohGTKangPLeeSSWLeeDSCLeeSYSelamatSMohd TaibNAYoonSYBRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family historyPLoS One20083e20241843150110.1371/journal.pone.0002024 DumitrescuRGCotarlaIUnderstanding breast cancer risk—where do we stand in 2005?J Cell Mol Med200592082211578417810.1111/j.1582-4934.2005.tb00350.x1:STN:280:DC%2BD2M7lt1Sjtw%3D%3D RoaBBBoydAAVolcikKRichardsCSAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nat Genet199614185187884119110.1038/ng1096-1851:CAS:528:DyaK28XmtVKntLs%3D FriedmanLSOstermeyerEASzaboCIDowdPLynchEDRowellSEKingMCConfirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNat Genet19948399404789449310.1038/ng1294-3991:CAS:528:DyaK2MXitl2hsb0%3D AbeliovichDKaduriLLererIWeinbergNAmirGSagiMZlotogoraJHechingNThe founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60 % of ovarian cancer and 30 % of early-onset breast cancer patients among Ashkenazi womenAm J Hum Genet19976050551490429091:CAS:528:DyaK2sXhvFGjtLY%3D HoussamiNCiattoSMartinelliFBonardiRDuffySWEarly detection of second breast cancers improves prognosis in breast cancer survivorsAnn Oncol200920150515101929731610.1093/annonc/mdp0371:STN:280:DC%2BD1MrnsVaqsw%3D%3D FodorFHWestonABleiweissIJMcCurdyLDWalshMMTartterPIBrowerSTEngCMFrequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patientsAm J Hum Genet1998634551963450410.1086/3019031:STN:280:DyaK1c3pvFOqtA%3D%3D MerajverSDPhamTMCaduffRFChenMPoyELCooneyKAWeberBLCollinsFSSomatic mutations in the BRCA1 gene in sporadic ovarian tumoursNat Genet19959439443779565210.1038/ng0495-4391:CAS:528:DyaK2MXkvV2ju7s%3D KumarBVLakhotiaSAnkhatilRMadhavanJJayaprakashPGNairMKSomasundaramKGermline BRCA1 mutation analysis in Indian breast/ovarian cancer familiesCancer Biol Ther200211821121707591:CAS:528:DC%2BD3sXlsVOkug%3D%3D LeeMSGreenRMarsillacSMCoquelleNWilliamsRSYeungTFooDHauDDComprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assaysCancer Res201070488048902051611510.1158/0008-5472.CAN-09-45631:CAS:528:DC%2BC3cXntlKlt7w%3D De SilvaWKarunanayakeEHTennekoonKHAllenMAmarasingheIAngunawalaPZiardMHNovel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individualsBMC Cancer200882141866240910.1186/1471-2407-8-214 HedauSJainNHusainSAMandalAKRayGShahidMKantRGuptaVNovel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from IndiaBreast Cancer Res Treat2004881771861556480010.1007/s10549-004-0593-81:CAS:528:DC%2BD2MXoslOktw%3D%3D EelesRAFuture possibilities in the prevention of breast cancer intervention strategies in BRCA1 and BRCA2 mutation carriersBreast Cancer Res200022832901125072210.1186/bcr701:CAS:528:DC%2BD3cXlvFOgt74%3D SaxenaSSzaboCIChopinSBarjhouxLSinilnikovaOLenoirGGoldgarDEBhatanagerDBRCA1 and BRCA2 in Indian breast cancer patientsHum Mutat2002204734741244227310.1002/humu.9082 RuffnerHJoazeiroCAPHemmatiDHunterTVermaIMCancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivityPNAS USA200198513451391132025010.1073/pnas.0810683981:CAS:528:DC%2BD3MXjt1Ons7s%3D DunningAMChianoMSmithNRDeardenJGoreMOakesSWilsonCStrattonMCommon BRCA1 variants and susceptibility to breast and ovarian cancer in the general populationHum Mol Genet19976285289906374910.1093/hmg/6.2.2851:CAS:528:DyaK2sXht1anur4%3D StruewingJPHartgePWacholderSBakerSMBerlinMMcAdamsMTimmermanMMBrodyLCThe risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsN Engl J Med199733614011408914567610.1056/NEJM1997051533620011:STN:280:DyaK2s3nsVShug%3D%3D Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, editors. Globocan 2008 v1.2. In: Cancer incidence and mortality worldwide: IARC Cancer Base No.10 Internet. Lyon France: International Agency for Research in Cancer; 2010. Available from: http://globocan.iarc.fr/. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Cancer Incidence in Five Continents, No. 160. Volume IX. Lyon, France: IARC Scientific Publications; 2007. 896 pp. MaloneKEDalingJRNealCSuterNMO’BrienCCushing-HaugenKJonasdottirTJThompsonJDFrequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma casesCancer200088139314021071762210.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P1:CAS:528:DC%2BD3cXisVentr0%3D JohannesdottirGGudmundssonJBergthorssonJTArasonAAgnarssonBAEiriksdottirGJohannssonOTBorgAHigh prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patientsCancer Res1996563663366587060041:CAS:528:DyaK28XltVKksro%3D ThorlaciusSSigurdssonSBjarnadottirHOlafsdottirGJonassonJGTryggvadottirLTuliniusHEyfjördJEStudy of a single BRCA2 mutation with high carrier frequency in a small populationAm J Hum Genet1997601079108491501551:STN:280:DyaK2s3psVequw%3D%3D LomanNJohannssonOKristofferssonUOlssonHBorgAFamily history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancerJ Natl Cancer Inst200193121512231150476710.1093/jnci/93.16.12151:CAS:528:DC%2BD3MXms1OrtLc%3D VaidyanathanKLakhotiaSRavishankarHMTabassumUMukherjeeGSomasundaramKBRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutationJ Biosci2009344154221980590310.1007/s12038-009-0048-91:CAS:528:DC%2BD1MXhtlCgtL3K OlopadeOIGrushkoTANandaRHuoDAdvances in breast cancer: pathways to personalized medicineClin Cancer Res200814798879991908801510.1158/1078-0432.CCR-08-12111:CAS:528:DC%2BD1cXhsV2it73L FrankTSDeffenbaughAMReidJEHulickMWardBELingenfelterBGumpperKLSchollTClinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individualsJ Clin Oncol200220148014901189609510.1200/JCO.20.6.14801:CAS:528:DC%2BD38XivFeisbY%3D ValarmathiMTSawhneyMDeoSSVShuklaNKDasSNNovel germline mutations in the BRCA1 and BRCA2 genes in Indian breast-ovarian cancer familiesHum Mutat2004232051472292610.1002/humu.9213 AbkevichVZharkikhADeffenbaughAMFrankDChenYShattuckDSkolnickMHGutinAAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variationJ Med Genet2004414925071523502010.1136/jmg.2003.0158671:CAS:528:DC%2BD2cXmvVymsLc%3D http://relibrca.rellife.com. ShihHANathansonKLSealSBlackwoodMARebbeckTRArmstrongKAWeberBLBRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancersClin Cancer Res2000642594264111062411:CAS:528:DC%2BD3cXovVSgtbc%3D MauriceAEvansDGShentonAAshcroftLBaildamABarrLByrneGBundredNScreening younger women with a family history of breast cancer—does early detection improve outcome?Eur J Cancer200642138513901675091010.1016/j.ejca.2006.01.0551:STN:280:DC%2BD28zmvFyitQ%3D%3D Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. In: Cancer incidence in five continents, No. 155. Volume VIII. Lyon, France: IARC Scientific Publications; 2002. 781 pp. JudkinsTHendricksonBCDeffenbaughAMEliasonKLeclairBNortonMJWardBEPrussDApplication of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutationsCancer Res20056510096101031626703610.1158/0008-5472.CAN-05-12411:CAS:528:DC%2BD2MXhtFKkt7rF ShihHACouchFJNathasonKLBlackwoodMARebbeckTRArmstrongKACalzoneKStopferJBRCA1 and BRCA2 mutations frequency in women evaluated in a breast cancer risk evaluation clinicJ Clin Oncol2002209949991184482210.1200/JCO.20.4.9941:CAS:528:DC%2BD38XitFOqtbc%3D SaxenaSChakraborthyAKauhsalMKotwalSBhatanagerDMohilRChintamaniCAggarwalAKContribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in northern IndiaBMC Med Genet20067751701816010.1186/1471-2350-7-75 RajkumarTSoumittraNNancyNKSwaminathanRSrideviVShantaVBRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South IndiaAsian Pac J Cancer Prev2003420320814507240 Shattuck-EidensDOliphantAMcClureMMcBrideCGupteJRubanoTPrussDTavtigianSVBRCA1 sequence analysis in women at high risk for susceptibility mutations risk factor analysis and implications for genetic testingJAMA199727812421250933326510.1001/jama.1997.035501500460341:CAS:528:DyaK2sXmvFemtLk%3D DurocherFShattuck-EidensDMcClureMLabrieFSkolnickMHGoldgarDESimardJComparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsHum Mol Genet19965835842877660010.1093/hmg/5.6.8351:CAS:528:DyaK28XjsFGmur4%3D National Cancer Registry ProgramConsolidated report of the population based cancer registries2001New DelhiIndian Council of Medical Research Breast Cancer Information Core (BIC) Database—NHGRI: research server: http://research.nhgri.nih.gov/bic/. T Rajkumar (294_CR20) 2003; 4 MS Lee (294_CR31) 2010; 70 GT Toh (294_CR37) 2008; 3 294_CR41 N Houssami (294_CR40) 2009; 20 LS Friedman (294_CR35) 1994; 8 RG Dumitrescu (294_CR5) 2005; 9 V Abkevich (294_CR29) 2004; 41 S Saxena (294_CR17) 2006; 7 T Judkins (294_CR22) 2005; 65 HA Shih (294_CR27) 2002; 20 SD Merajver (294_CR38) 1995; 9 S Hedau (294_CR14) 2004; 88 D Abeliovich (294_CR23) 1997; 60 TS Frank (294_CR21) 2002; 20 AM Dunning (294_CR33) 1997; 6 W Silva De (294_CR36) 2008; 8 MT Valarmathi (294_CR18) 2004; 23 JP Struewing (294_CR11) 1997; 336 HA Shih (294_CR28) 2000; 6 BV Kumar (294_CR15) 2002; 1 KE Malone (294_CR26) 2000; 88 H Ruffner (294_CR32) 2001; 98 D Shattuck-Eidens (294_CR30) 1997; 278 OI Olopade (294_CR6) 2008; 14 FH Fodor (294_CR9) 1998; 63 294_CR8 294_CR1 S Thorlacius (294_CR24) 1997; 60 294_CR2 RA Eeles (294_CR7) 2000; 2 BB Roa (294_CR10) 1996; 14 294_CR3 National Cancer Registry Program (294_CR4) 2001 A Maurice (294_CR39) 2006; 42 F Durocher (294_CR34) 1996; 5 S Saxena (294_CR16) 2002; 20 K Vaidyanathan (294_CR19) 2009; 34 G Johannesdottir (294_CR12) 1996; 56 S Thorlacius (294_CR13) 1997; 60 N Loman (294_CR25) 2001; 93 14507240 - Asian Pac J Cancer Prev. 2003 Jul-Sep;4(3):203-8 15564800 - Breast Cancer Res Treat. 2004 Nov;88(2):177-86 16267036 - Cancer Res. 2005 Nov 1;65(21):10096-103 9063749 - Hum Mol Genet. 1997 Feb;6(2):285-9 7795652 - Nat Genet. 1995 Apr;9(4):439-43 19805903 - J Biosci. 2009 Sep;34(3):415-22 19297316 - Ann Oncol. 2009 Sep;20(9):1505-10 18431501 - PLoS One. 2008 Apr 23;3(4):e2024 9145676 - N Engl J Med. 1997 May 15;336(20):1401-8 17018160 - BMC Med Genet. 2006 Oct 04;7:75 15235020 - J Med Genet. 2004 Jul;41(7):492-507 9150155 - Am J Hum Genet. 1997 May;60(5):1079-84 9042909 - Am J Hum Genet. 1997 Mar;60(3):505-14 8841191 - Nat Genet. 1996 Oct;14(2):185-7 15784178 - J Cell Mol Med. 2005 Jan-Mar;9(1):208-21 9333265 - JAMA. 1997 Oct 15;278(15):1242-50 8706004 - Cancer Res. 1996 Aug 15;56(16):3663-5 11896095 - J Clin Oncol. 2002 Mar 15;20(6):1480-90 11250722 - Breast Cancer Res. 2000;2(4):283-90 18662409 - BMC Cancer. 2008 Jul 29;8:214 16750910 - Eur J Cancer. 2006 Jul;42(10):1385-90 11504767 - J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23 11320250 - Proc Natl Acad Sci U S A. 2001 Apr 24;98 (9):5134-9 10717622 - Cancer. 2000 Mar 15;88(6):1393-402 9634504 - Am J Hum Genet. 1998 Jul;63(1):45-51 19088015 - Clin Cancer Res. 2008 Dec 15;14(24):7988-99 7894493 - Nat Genet. 1994 Dec;8(4):399-404 20516115 - Cancer Res. 2010 Jun 15;70(12):4880-90 11106241 - Clin Cancer Res. 2000 Nov;6(11):4259-64 12170759 - Cancer Biol Ther. 2002 Jan-Feb;1(1):18-21 11844822 - J Clin Oncol. 2002 Feb 15;20(4):994-9 12442273 - Hum Mutat. 2002 Dec;20(6):473-4 8776600 - Hum Mol Genet. 1996 Jun;5(6):835-42 14722926 - Hum Mutat. 2004 Feb;23(2):205 |
References_xml | – reference: HoussamiNCiattoSMartinelliFBonardiRDuffySWEarly detection of second breast cancers improves prognosis in breast cancer survivorsAnn Oncol200920150515101929731610.1093/annonc/mdp0371:STN:280:DC%2BD1MrnsVaqsw%3D%3D – reference: RajkumarTSoumittraNNancyNKSwaminathanRSrideviVShantaVBRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South IndiaAsian Pac J Cancer Prev2003420320814507240 – reference: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P, editors. Cancer Incidence in Five Continents, No. 160. Volume IX. Lyon, France: IARC Scientific Publications; 2007. 896 pp. – reference: JudkinsTHendricksonBCDeffenbaughAMEliasonKLeclairBNortonMJWardBEPrussDApplication of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutationsCancer Res20056510096101031626703610.1158/0008-5472.CAN-05-12411:CAS:528:DC%2BD2MXhtFKkt7rF – reference: SaxenaSSzaboCIChopinSBarjhouxLSinilnikovaOLenoirGGoldgarDEBhatanagerDBRCA1 and BRCA2 in Indian breast cancer patientsHum Mutat2002204734741244227310.1002/humu.9082 – reference: DurocherFShattuck-EidensDMcClureMLabrieFSkolnickMHGoldgarDESimardJComparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsHum Mol Genet19965835842877660010.1093/hmg/5.6.8351:CAS:528:DyaK28XjsFGmur4%3D – reference: LomanNJohannssonOKristofferssonUOlssonHBorgAFamily history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancerJ Natl Cancer Inst200193121512231150476710.1093/jnci/93.16.12151:CAS:528:DC%2BD3MXms1OrtLc%3D – reference: De SilvaWKarunanayakeEHTennekoonKHAllenMAmarasingheIAngunawalaPZiardMHNovel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individualsBMC Cancer200882141866240910.1186/1471-2407-8-214 – reference: National Cancer Registry ProgramConsolidated report of the population based cancer registries2001New DelhiIndian Council of Medical Research – reference: AbeliovichDKaduriLLererIWeinbergNAmirGSagiMZlotogoraJHechingNThe founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60 % of ovarian cancer and 30 % of early-onset breast cancer patients among Ashkenazi womenAm J Hum Genet19976050551490429091:CAS:528:DyaK2sXhvFGjtLY%3D – reference: ThorlaciusSSigurdssonSBjarnadottirHOlafsdottirGJonassonJGTryggvadottirLTuliniusHEyfjördJEStudy of a single BRCA2 mutation with high carrier frequency in a small populationAm J Hum Genet1997601079108491501551:STN:280:DyaK2s3psVequw%3D%3D – reference: KumarBVLakhotiaSAnkhatilRMadhavanJJayaprakashPGNairMKSomasundaramKGermline BRCA1 mutation analysis in Indian breast/ovarian cancer familiesCancer Biol Ther200211821121707591:CAS:528:DC%2BD3sXlsVOkug%3D%3D – reference: MerajverSDPhamTMCaduffRFChenMPoyELCooneyKAWeberBLCollinsFSSomatic mutations in the BRCA1 gene in sporadic ovarian tumoursNat Genet19959439443779565210.1038/ng0495-4391:CAS:528:DyaK2MXkvV2ju7s%3D – reference: JohannesdottirGGudmundssonJBergthorssonJTArasonAAgnarssonBAEiriksdottirGJohannssonOTBorgAHigh prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patientsCancer Res1996563663366587060041:CAS:528:DyaK28XltVKksro%3D – reference: DunningAMChianoMSmithNRDeardenJGoreMOakesSWilsonCStrattonMCommon BRCA1 variants and susceptibility to breast and ovarian cancer in the general populationHum Mol Genet19976285289906374910.1093/hmg/6.2.2851:CAS:528:DyaK2sXht1anur4%3D – reference: OlopadeOIGrushkoTANandaRHuoDAdvances in breast cancer: pathways to personalized medicineClin Cancer Res200814798879991908801510.1158/1078-0432.CCR-08-12111:CAS:528:DC%2BD1cXhsV2it73L – reference: SaxenaSChakraborthyAKauhsalMKotwalSBhatanagerDMohilRChintamaniCAggarwalAKContribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in northern IndiaBMC Med Genet20067751701816010.1186/1471-2350-7-75 – reference: FriedmanLSOstermeyerEASzaboCIDowdPLynchEDRowellSEKingMCConfirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten familiesNat Genet19948399404789449310.1038/ng1294-3991:CAS:528:DyaK2MXitl2hsb0%3D – reference: LeeMSGreenRMarsillacSMCoquelleNWilliamsRSYeungTFooDHauDDComprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assaysCancer Res201070488048902051611510.1158/0008-5472.CAN-09-45631:CAS:528:DC%2BC3cXntlKlt7w%3D – reference: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. In: Cancer incidence in five continents, No. 155. Volume VIII. Lyon, France: IARC Scientific Publications; 2002. 781 pp. – reference: StruewingJPHartgePWacholderSBakerSMBerlinMMcAdamsMTimmermanMMBrodyLCThe risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi JewsN Engl J Med199733614011408914567610.1056/NEJM1997051533620011:STN:280:DyaK2s3nsVShug%3D%3D – reference: Breast Cancer Information Core (BIC) Database—NHGRI: research server: http://research.nhgri.nih.gov/bic/. – reference: MauriceAEvansDGShentonAAshcroftLBaildamABarrLByrneGBundredNScreening younger women with a family history of breast cancer—does early detection improve outcome?Eur J Cancer200642138513901675091010.1016/j.ejca.2006.01.0551:STN:280:DC%2BD28zmvFyitQ%3D%3D – reference: DumitrescuRGCotarlaIUnderstanding breast cancer risk—where do we stand in 2005?J Cell Mol Med200592082211578417810.1111/j.1582-4934.2005.tb00350.x1:STN:280:DC%2BD2M7lt1Sjtw%3D%3D – reference: ValarmathiMTSawhneyMDeoSSVShuklaNKDasSNNovel germline mutations in the BRCA1 and BRCA2 genes in Indian breast-ovarian cancer familiesHum Mutat2004232051472292610.1002/humu.9213 – reference: MaloneKEDalingJRNealCSuterNMO’BrienCCushing-HaugenKJonasdottirTJThompsonJDFrequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma casesCancer200088139314021071762210.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P1:CAS:528:DC%2BD3cXisVentr0%3D – reference: RuffnerHJoazeiroCAPHemmatiDHunterTVermaIMCancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivityPNAS USA200198513451391132025010.1073/pnas.0810683981:CAS:528:DC%2BD3MXjt1Ons7s%3D – reference: RoaBBBoydAAVolcikKRichardsCSAshkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2Nat Genet199614185187884119110.1038/ng1096-1851:CAS:528:DyaK28XmtVKntLs%3D – reference: AbkevichVZharkikhADeffenbaughAMFrankDChenYShattuckDSkolnickMHGutinAAnalysis of missense variation in human BRCA1 in the context of interspecific sequence variationJ Med Genet2004414925071523502010.1136/jmg.2003.0158671:CAS:528:DC%2BD2cXmvVymsLc%3D – reference: ShihHACouchFJNathasonKLBlackwoodMARebbeckTRArmstrongKACalzoneKStopferJBRCA1 and BRCA2 mutations frequency in women evaluated in a breast cancer risk evaluation clinicJ Clin Oncol2002209949991184482210.1200/JCO.20.4.9941:CAS:528:DC%2BD38XitFOqtbc%3D – reference: http://relibrca.rellife.com. – reference: FodorFHWestonABleiweissIJMcCurdyLDWalshMMTartterPIBrowerSTEngCMFrequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patientsAm J Hum Genet1998634551963450410.1086/3019031:STN:280:DyaK1c3pvFOqtA%3D%3D – reference: FrankTSDeffenbaughAMReidJEHulickMWardBELingenfelterBGumpperKLSchollTClinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individualsJ Clin Oncol200220148014901189609510.1200/JCO.20.6.14801:CAS:528:DC%2BD38XivFeisbY%3D – reference: Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, editors. Globocan 2008 v1.2. In: Cancer incidence and mortality worldwide: IARC Cancer Base No.10 Internet. Lyon France: International Agency for Research in Cancer; 2010. Available from: http://globocan.iarc.fr/. – reference: EelesRAFuture possibilities in the prevention of breast cancer intervention strategies in BRCA1 and BRCA2 mutation carriersBreast Cancer Res200022832901125072210.1186/bcr701:CAS:528:DC%2BD3cXlvFOgt74%3D – reference: ShihHANathansonKLSealSBlackwoodMARebbeckTRArmstrongKAWeberBLBRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancersClin Cancer Res2000642594264111062411:CAS:528:DC%2BD3cXovVSgtbc%3D – reference: HedauSJainNHusainSAMandalAKRayGShahidMKantRGuptaVNovel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from IndiaBreast Cancer Res Treat2004881771861556480010.1007/s10549-004-0593-81:CAS:528:DC%2BD2MXoslOktw%3D%3D – reference: VaidyanathanKLakhotiaSRavishankarHMTabassumUMukherjeeGSomasundaramKBRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutationJ Biosci2009344154221980590310.1007/s12038-009-0048-91:CAS:528:DC%2BD1MXhtlCgtL3K – reference: Shattuck-EidensDOliphantAMcClureMMcBrideCGupteJRubanoTPrussDTavtigianSVBRCA1 sequence analysis in women at high risk for susceptibility mutations risk factor analysis and implications for genetic testingJAMA199727812421250933326510.1001/jama.1997.035501500460341:CAS:528:DyaK2sXmvFemtLk%3D – reference: TohGTKangPLeeSSWLeeDSCLeeSYSelamatSMohd TaibNAYoonSYBRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family historyPLoS One20083e20241843150110.1371/journal.pone.0002024 – volume: 88 start-page: 177 year: 2004 ident: 294_CR14 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-004-0593-8 – volume: 88 start-page: 1393 year: 2000 ident: 294_CR26 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P – volume: 63 start-page: 45 year: 1998 ident: 294_CR9 publication-title: Am J Hum Genet doi: 10.1086/301903 – volume: 4 start-page: 203 year: 2003 ident: 294_CR20 publication-title: Asian Pac J Cancer Prev – volume: 5 start-page: 835 year: 1996 ident: 294_CR34 publication-title: Hum Mol Genet doi: 10.1093/hmg/5.6.835 – volume: 9 start-page: 208 year: 2005 ident: 294_CR5 publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2005.tb00350.x – volume: 6 start-page: 4259 year: 2000 ident: 294_CR28 publication-title: Clin Cancer Res – volume: 20 start-page: 994 year: 2002 ident: 294_CR27 publication-title: J Clin Oncol doi: 10.1200/JCO.20.4.994 – ident: 294_CR8 – volume: 1 start-page: 18 year: 2002 ident: 294_CR15 publication-title: Cancer Biol Ther doi: 10.4161/cbt.1.1.33 – volume: 70 start-page: 4880 year: 2010 ident: 294_CR31 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-4563 – volume: 8 start-page: 399 year: 1994 ident: 294_CR35 publication-title: Nat Genet doi: 10.1038/ng1294-399 – volume: 2 start-page: 283 year: 2000 ident: 294_CR7 publication-title: Breast Cancer Res doi: 10.1186/bcr70 – volume: 34 start-page: 415 year: 2009 ident: 294_CR19 publication-title: J Biosci doi: 10.1007/s12038-009-0048-9 – ident: 294_CR1 – ident: 294_CR3 – volume: 65 start-page: 10096 year: 2005 ident: 294_CR22 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-1241 – volume-title: Consolidated report of the population based cancer registries year: 2001 ident: 294_CR4 – volume: 14 start-page: 7988 year: 2008 ident: 294_CR6 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-1211 – volume: 60 start-page: 1079 year: 1997 ident: 294_CR24 publication-title: Am J Hum Genet – volume: 60 start-page: 1079 year: 1997 ident: 294_CR13 publication-title: Am J Hum Genet – volume: 56 start-page: 3663 year: 1996 ident: 294_CR12 publication-title: Cancer Res – volume: 336 start-page: 1401 year: 1997 ident: 294_CR11 publication-title: N Engl J Med doi: 10.1056/NEJM199705153362001 – volume: 6 start-page: 285 year: 1997 ident: 294_CR33 publication-title: Hum Mol Genet doi: 10.1093/hmg/6.2.285 – ident: 294_CR41 – volume: 93 start-page: 1215 year: 2001 ident: 294_CR25 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/93.16.1215 – volume: 7 start-page: 75 year: 2006 ident: 294_CR17 publication-title: BMC Med Genet doi: 10.1186/1471-2350-7-75 – volume: 14 start-page: 185 year: 1996 ident: 294_CR10 publication-title: Nat Genet doi: 10.1038/ng1096-185 – volume: 20 start-page: 473 year: 2002 ident: 294_CR16 publication-title: Hum Mutat doi: 10.1002/humu.9082 – volume: 23 start-page: 205 year: 2004 ident: 294_CR18 publication-title: Hum Mutat doi: 10.1002/humu.9213 – volume: 41 start-page: 492 year: 2004 ident: 294_CR29 publication-title: J Med Genet doi: 10.1136/jmg.2003.015867 – ident: 294_CR2 – volume: 20 start-page: 1505 year: 2009 ident: 294_CR40 publication-title: Ann Oncol doi: 10.1093/annonc/mdp037 – volume: 8 start-page: 214 year: 2008 ident: 294_CR36 publication-title: BMC Cancer doi: 10.1186/1471-2407-8-214 – volume: 3 start-page: e2024 year: 2008 ident: 294_CR37 publication-title: PLoS One doi: 10.1371/journal.pone.0002024 – volume: 20 start-page: 1480 year: 2002 ident: 294_CR21 publication-title: J Clin Oncol doi: 10.1200/JCO.20.6.1480 – volume: 60 start-page: 505 year: 1997 ident: 294_CR23 publication-title: Am J Hum Genet – volume: 42 start-page: 1385 year: 2006 ident: 294_CR39 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2006.01.055 – volume: 278 start-page: 1242 year: 1997 ident: 294_CR30 publication-title: JAMA doi: 10.1001/jama.1997.03550150046034 – volume: 98 start-page: 5134 year: 2001 ident: 294_CR32 publication-title: PNAS USA doi: 10.1073/pnas.081068398 – volume: 9 start-page: 439 year: 1995 ident: 294_CR38 publication-title: Nat Genet doi: 10.1038/ng0495-439 – reference: 15564800 - Breast Cancer Res Treat. 2004 Nov;88(2):177-86 – reference: 14507240 - Asian Pac J Cancer Prev. 2003 Jul-Sep;4(3):203-8 – reference: 15784178 - J Cell Mol Med. 2005 Jan-Mar;9(1):208-21 – reference: 8841191 - Nat Genet. 1996 Oct;14(2):185-7 – reference: 8706004 - Cancer Res. 1996 Aug 15;56(16):3663-5 – reference: 19088015 - Clin Cancer Res. 2008 Dec 15;14(24):7988-99 – reference: 7894493 - Nat Genet. 1994 Dec;8(4):399-404 – reference: 9145676 - N Engl J Med. 1997 May 15;336(20):1401-8 – reference: 11844822 - J Clin Oncol. 2002 Feb 15;20(4):994-9 – reference: 16750910 - Eur J Cancer. 2006 Jul;42(10):1385-90 – reference: 16267036 - Cancer Res. 2005 Nov 1;65(21):10096-103 – reference: 11504767 - J Natl Cancer Inst. 2001 Aug 15;93(16):1215-23 – reference: 17018160 - BMC Med Genet. 2006 Oct 04;7:75 – reference: 20516115 - Cancer Res. 2010 Jun 15;70(12):4880-90 – reference: 7795652 - Nat Genet. 1995 Apr;9(4):439-43 – reference: 15235020 - J Med Genet. 2004 Jul;41(7):492-507 – reference: 11106241 - Clin Cancer Res. 2000 Nov;6(11):4259-64 – reference: 14722926 - Hum Mutat. 2004 Feb;23(2):205 – reference: 11320250 - Proc Natl Acad Sci U S A. 2001 Apr 24;98 (9):5134-9 – reference: 9634504 - Am J Hum Genet. 1998 Jul;63(1):45-51 – reference: 9333265 - JAMA. 1997 Oct 15;278(15):1242-50 – reference: 9063749 - Hum Mol Genet. 1997 Feb;6(2):285-9 – reference: 12442273 - Hum Mutat. 2002 Dec;20(6):473-4 – reference: 19805903 - J Biosci. 2009 Sep;34(3):415-22 – reference: 9150155 - Am J Hum Genet. 1997 May;60(5):1079-84 – reference: 19297316 - Ann Oncol. 2009 Sep;20(9):1505-10 – reference: 18431501 - PLoS One. 2008 Apr 23;3(4):e2024 – reference: 9042909 - Am J Hum Genet. 1997 Mar;60(3):505-14 – reference: 11896095 - J Clin Oncol. 2002 Mar 15;20(6):1480-90 – reference: 10717622 - Cancer. 2000 Mar 15;88(6):1393-402 – reference: 11250722 - Breast Cancer Res. 2000;2(4):283-90 – reference: 8776600 - Hum Mol Genet. 1996 Jun;5(6):835-42 – reference: 18662409 - BMC Cancer. 2008 Jul 29;8:214 – reference: 12170759 - Cancer Biol Ther. 2002 Jan-Feb;1(1):18-21 |
SSID | ssj0021529 |
Score | 2.065702 |
Snippet | We examined BRCA1/2 mutations and single nucleotide polymorphisms (SNPs) for identification of BRCA1 haplotypes, in early-onset breast cancer patients and... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3272 |
SubjectTerms | Adult Age of Onset Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - genetics DNA Mutational Analysis Female Genes, BRCA1 Genes, BRCA2 Haplotypes Hematology Humans India - epidemiology Internal Medicine Medicine Medicine & Public Health Middle Aged Mutation Oncology Original Paper Pathology Polymorphism, Single Nucleotide Reverse Transcriptase Polymerase Chain Reaction |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9wwDI8Ge-EFMbFB-ZgyaU-giLSXNskTYmgIJg1NfEj3VuWrAgnSg_b-f-xe7m4T2j20L3Uly3ZiO3Z-JuQ7t9xJWRmmR1VgIlSKqUoF1oArVxhi-4CXk39fV5f34te4HKcDty61Vc73xGGj9q3DM_KTHFFlJES3_HTywnBqFFZX0wiNNfIRocuwpUuOlwkX-CY9JFylZODoF1XN4eocjg6HRBqeQgum__VL74LNd4XSwf9cbJHNFDjSs5mmP5EPIW6T-OPm_Cw_wXdBwRQCfZ72qRp9e_2noyZ6OtDQBzN5avHAtaOPkQbENWbYSd1Ti33pPXWo_1eagFY72jb0KqL10NA_xEcH4fpncn_x8-78kqUJCsxBINaz3IvKKt447QvQw0h7boxpRrm3uW-sLRHbBnLU0orGSoPgeII7z0unnVZNGH0h67GNYZdQ52TDQym1FUpopYzPpddahkJVDmKMjPC5_GqX4MVxysVTvQRGRpHXIPIaRV7rjBwtfpnMsDVWER_MlVKnZdbVS6PIyLfFZ1ggWPUwMbRToCmw1go0agUNfEYgRFVlZGem8AVHRSFLSPpERo7nFvAXA_9jd281u_tko0DbG_piDsh6_zoNhxDd9PbrYMJvm1zycg priority: 102 providerName: ProQuest |
Title | BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity |
URI | https://link.springer.com/article/10.1007/s12032-012-0294-9 https://www.ncbi.nlm.nih.gov/pubmed/22752604 https://www.proquest.com/docview/1732877580 https://www.proquest.com/docview/1220367588 https://www.proquest.com/docview/1758239886 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9QwDLfYJiFeEN8UxilIPIEi0lzbJI-36cYA7TQNTjqeqnxVQxq9ae098N9j99oONJjEQ9uHuK1lO7VdO78AvBFOeKUKy820iDyLhea60JFX6Mo1hdgh0uLkk0VxvMw-rfJVv467Gbrdh5Jk96W-XuxGm31j6ouHNBk3O7CXU-qORryUszHLQodkuiwrVxy9-1jK_Nsj_nRGNyLMG9XRzukcPYD7fbTIZlv1PoQ7sX4Ed0_6evhjqA_ODmfpezpLhqYQ2Y9N21ejvyxOG2brwDoadm4vL9b0w7Vh32sWCdeYUyd1yxz1pbfMk_6vWA-02rB1xT7WZD0stuc1vrD9-QSWR_Ovh8e830GBewzEWp6GrHBaVN4EiXqYmiCstdU0DS4NlXM5Ydtgjpq7rHLKEjheJnwQuTfe6CpOn8Juva7jc2Deq0rEXBmX6cxobUOqgjEqSl14jDESEIMoS9_Di9MuFxflNTAySb9E6Zck_dIk8Ha85XKLrXEb8f6gn7KfZk2ZEtSQwpRHJPB6HMYJQlUPW8f1Bmkk1VqRRt9Cg8MEhKiLBJ5tdT9yJKXKMenLEng3GMNvDPyL3Rf_Rf0S7kmyyq5NZh9226tNfIXBTusmsKNWagJ7sw_fPs_xejBfnJ5NOpP_Bdca9iU |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEuCMQrUMBIcAFZTZyH7QNCbWm1S9tVVVqptxA_olYqydLNCvGn-I3MZJMUVLG3HpKLJ9Fo_Nme8djfALwNTWilzAqu48zzxGeKq0x5XuJSrsjFdp4uJx9Os_Fp8uUsPVuD3_1dGDpW2c-J7UTtakt75JsRscpI9G7DT7MfnKpGUXa1L6GxhMW-__UTQ7b5x8ln7N93QuztnuyMeVdVgFt0ThoeuSQzKiytdgJ1i7ULi6Io48iZyJXGpMT3gnFbapLSyIII45LQujC12mpV-hj_ewfWkxhDmRGsb-9Oj46HEA9XQ92GeKnk6FoMedT2sh4VK8fQHR-hE67_XQlvuLc3UrPtirf3AO53rirbWmLrIaz56hFU28c7W9EmvQVD8Hn2fdF0-e-v06M5KyrHWhl2Xswua9rinbOLinliUuZ0drthhk7CN8wS4q5YR-06Z3XJJhXhlfnmvLqwGCA8htNbse4TGFV15Z8Bs1aWoU-lNolKtFKFi6TTWnqhMoteTQBhb7_cdoTmVFfjMr-mYiaT52jynEye6wDeD5_Mlmweq4Q3-k7Ju4E9z69hGMCboRmHJOVZisrXC5QRlN1FGbVCBpuJelFlATxddvigkRAyxTAzCeBDj4C_FPifus9Xq_sa7o5PDg_yg8l0_wXcE4TD9lTOBoyaq4V_ib5VY151gGbw7bbH0B-majGk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIiEuqIiXocAiwQW0ir1-7O4BodISNRSiCqiUm_E-rFYqdlo7Qvw1fh0zjp2AKnLrwbl4Yo1mv_HOeGa_AXgZmtBKmRVcx5nnic8UV5nyvMStXFGI7TwdTv48zQ5Pko-zdLYFv4ezMNRWObwTuxe1qy19Ix9FxCojMboNR2XfFnF8MH43v-A0QYoqrcM4jSVEjvyvn5i-NW8nB7jWr4QYf_i2f8j7CQPcYqDS8sglmVFhabUTqGesXVgURRlHzkSuNCYl7hfM4VKTlEYWRB6XhNaFqdVWq9LH-NwbcFPGaUQ-JmfrZA_3Rd0le6nkGGSsKqrdsT0aW45JPF5CJ1z_uydeCXSvFGm7vW-8A3f6oJXtLVF2F7Z8dQ-q91_296IR_QqGMPTsx6LtK-Ffp8cNKyrHOhl2WszPa_rY27CzinniVObUxd0yQz3xLbOEvUvWk7w2rC7ZpCLkMt-eVmcWU4X7cHIttn0A21Vd-UfArJVl6FOpTaISrVThIum0ll6ozGJ8E0A42C-3PbU5Tdg4z9ekzGTyHE2ek8lzHcDr1V_mS16PTcK7w6LkvYs3-RqQAbxY3UbnpIpLUfl6gTKC6rwoozbI4G0iYVRZAA-XC77SSAiZYsKZBPBmQMBfCvxP3ceb1X0Ot9Bz8k-T6dETuC0Ihl17zi5st5cL_xSDrNY869DM4Pt1u88fwss0dA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BRCA1%2FBRCA2+gene+mutations%2FSNPs+and+BRCA1+haplotypes+in+early-onset+breast+cancer+patients+of+Indian+ethnicity&rft.jtitle=Medical+oncology+%28Northwood%2C+London%2C+England%29&rft.au=Juwle%2C+Abida&rft.au=Saranath%2C+Dhananjaya&rft.date=2012-12-01&rft.pub=Springer+US&rft.issn=1357-0560&rft.eissn=1559-131X&rft.volume=29&rft.issue=5&rft.spage=3272&rft.epage=3281&rft_id=info:doi/10.1007%2Fs12032-012-0294-9&rft.externalDocID=10_1007_s12032_012_0294_9 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1357-0560&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1357-0560&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1357-0560&client=summon |